PERITONITIS AND PERITONEAL DIALYSIS.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

5 Citations (Scopus)

Abstract

It appears that about one-third of the patients develop peritonitis through the lumen of the catheter and about 25% from exit site infections, periluminally. Approximately 30% of patients will develop peritonitis with enteric organisms, out of which one-third (10% of the patients) will have fecal peritonitis. Another 10% will develop peritonitis through hematogenous routes. Treatment of peritonitis is dependent on the following principles: early and accurate diagnosis of peritonitis; use of appropriate antibiotics in appropriate concentration; complications due to peritonitis have been reduced by early and aggressive treatment. Future development has to concentrate on development of new material for catheters, and development of therapeutic modalities with prepackaged antibiotic or antibiotic combination should be explored.

Original languageEnglish
Title of host publicationTransactions - American Society for Artificial Internal Organs
Pages682-684
Number of pages3
Volume30
Publication statusPublished - 1984

Fingerprint

Dialysis
Peritoneal Dialysis
Antibiotics
Peritonitis
Catheters
Anti-Bacterial Agents
Early Diagnosis
Therapeutics
Infection

ASJC Scopus subject areas

  • Engineering(all)
  • Medicine(all)

Cite this

Vas, S. (1984). PERITONITIS AND PERITONEAL DIALYSIS. In Transactions - American Society for Artificial Internal Organs (Vol. 30, pp. 682-684)

PERITONITIS AND PERITONEAL DIALYSIS. / Vas, S.

Transactions - American Society for Artificial Internal Organs. Vol. 30 1984. p. 682-684.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Vas, S 1984, PERITONITIS AND PERITONEAL DIALYSIS. in Transactions - American Society for Artificial Internal Organs. vol. 30, pp. 682-684.
Vas S. PERITONITIS AND PERITONEAL DIALYSIS. In Transactions - American Society for Artificial Internal Organs. Vol. 30. 1984. p. 682-684
Vas, S. / PERITONITIS AND PERITONEAL DIALYSIS. Transactions - American Society for Artificial Internal Organs. Vol. 30 1984. pp. 682-684
@inproceedings{1098965a2bf1476e8dd98b9c37b93268,
title = "PERITONITIS AND PERITONEAL DIALYSIS.",
abstract = "It appears that about one-third of the patients develop peritonitis through the lumen of the catheter and about 25{\%} from exit site infections, periluminally. Approximately 30{\%} of patients will develop peritonitis with enteric organisms, out of which one-third (10{\%} of the patients) will have fecal peritonitis. Another 10{\%} will develop peritonitis through hematogenous routes. Treatment of peritonitis is dependent on the following principles: early and accurate diagnosis of peritonitis; use of appropriate antibiotics in appropriate concentration; complications due to peritonitis have been reduced by early and aggressive treatment. Future development has to concentrate on development of new material for catheters, and development of therapeutic modalities with prepackaged antibiotic or antibiotic combination should be explored.",
author = "S. Vas",
year = "1984",
language = "English",
volume = "30",
pages = "682--684",
booktitle = "Transactions - American Society for Artificial Internal Organs",

}

TY - GEN

T1 - PERITONITIS AND PERITONEAL DIALYSIS.

AU - Vas, S.

PY - 1984

Y1 - 1984

N2 - It appears that about one-third of the patients develop peritonitis through the lumen of the catheter and about 25% from exit site infections, periluminally. Approximately 30% of patients will develop peritonitis with enteric organisms, out of which one-third (10% of the patients) will have fecal peritonitis. Another 10% will develop peritonitis through hematogenous routes. Treatment of peritonitis is dependent on the following principles: early and accurate diagnosis of peritonitis; use of appropriate antibiotics in appropriate concentration; complications due to peritonitis have been reduced by early and aggressive treatment. Future development has to concentrate on development of new material for catheters, and development of therapeutic modalities with prepackaged antibiotic or antibiotic combination should be explored.

AB - It appears that about one-third of the patients develop peritonitis through the lumen of the catheter and about 25% from exit site infections, periluminally. Approximately 30% of patients will develop peritonitis with enteric organisms, out of which one-third (10% of the patients) will have fecal peritonitis. Another 10% will develop peritonitis through hematogenous routes. Treatment of peritonitis is dependent on the following principles: early and accurate diagnosis of peritonitis; use of appropriate antibiotics in appropriate concentration; complications due to peritonitis have been reduced by early and aggressive treatment. Future development has to concentrate on development of new material for catheters, and development of therapeutic modalities with prepackaged antibiotic or antibiotic combination should be explored.

UR - http://www.scopus.com/inward/record.url?scp=0021610876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021610876&partnerID=8YFLogxK

M3 - Conference contribution

VL - 30

SP - 682

EP - 684

BT - Transactions - American Society for Artificial Internal Organs

ER -